Vanguard Fiduciary Trust
INBX icon

Vanguard Fiduciary Trust’s Inhibrx INBX Stock Holding History

Vanguard Fiduciary Trust’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.62M Buy
69,920
+5,598
+9% +$561K ﹤0.01% 2031
2026
Q1 		$4.32M Buy
+64,322
New +$4.77M ﹤0.01% 2157

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust's INBX Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Inhibrx (INBX) stake by 8.7% in Q2 2026, buying an estimated $561K and bringing the position to 69,920 shares worth $6.62M. The position accounts for ﹤0.01% of the portfolio, ranked #2031.

Vanguard Fiduciary Trust first reported a position in INBX in Q1 2026 and has held it in 2 quarters since. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Vanguard Fiduciary Trust held 69,920 shares of Inhibrx worth $6.62M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 5,598 Inhibrx shares in Q2 2026, an estimated $561K.
  • Inhibrx made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2031 holding.
  • Vanguard Fiduciary Trust first reported a position in Inhibrx in Q1 2026 and has held it in 2 quarters since.
  • 163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.